Lochheed, Melissa External Entity

Publications

Sort by

Selected publications

  • Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma.  European journal of cancer (Oxford, England : 1990)2014 Academic Article GET IT
    Times cited: 27

Other